Clinical practice for migraine treatment and characteristics of medical facilities and physicians treating migraine: Insights from a retrospective cohort study using a Japanese claims database
The real-world treatment patterns at medical facilities and their physicians' specialties treating migraine have not been fully investigated in Japan. Therefore, a retrospective cohort study aimed to describe real-world clinical practice and treatment patterns in Japanese patients with migraine...
Gespeichert in:
| Veröffentlicht in: | PloS one 2024-12, Vol.19 (12), p.e0315610 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 12 |
| container_start_page | e0315610 |
| container_title | PloS one |
| container_volume | 19 |
| creator | Takizawa, Tsubasa Kitano, Takahiro Togo, Kanae Yoshikawa, Reiko Iijima, Masahiro |
| description | The real-world treatment patterns at medical facilities and their physicians' specialties treating migraine have not been fully investigated in Japan. Therefore, a retrospective cohort study aimed to describe real-world clinical practice and treatment patterns in Japanese patients with migraine according to medical facilities and physicians' specialties. Anonymized claims data of patients with migraine was obtained from JMDC Inc (January 2018-June 2023). Patient characteristics and treatment pattern according to medical facilities and physicians' specialties treating migraine were evaluated. Of 231,156 patients with migraine (mean age [SD], 38.8 [11.8] years; females, 65.3%), 81.8% had the first prescription at clinics (CPs), 42.5% underwent imaging tests, 44.4% visited general internal medicine, and 25.9% consulted neurosurgery at initial diagnosis. Imaging tests were carried out at CPs with specialists (59.4%), hospitals (HPs) with specialists (59.1%), HPs (32.9%), and CPs (26.9%) without specialists. Overall, 95.6% received acute treatment while 21.8% received preventive treatment. At facilities with specialists compared to without specialists, triptans were more frequently prescribed (67.9% vs 44.9%) whereas acetaminophen and nonsteroidal anti-inflammatory drugs were less frequently prescribed (52.4% vs 69.2%). Preventive treatment use was higher at facilities with specialists (27.4%) than without specialists (15.7%) and increased annually regardless of the type of medical institution. In Japan, only half of patients with migraine visited facilities with specialists at their first diagnosis, and specialists are more likely use migraine-specific and preventive drugs than nonspecialists. Therefore, there is a need for awareness among migraine patients that they should consult specialists and for enhancement of medical collaboration between specialists and nonspecialists. |
| doi_str_mv | 10.1371/journal.pone.0315610 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_3147411728</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A820571074</galeid><doaj_id>oai_doaj_org_article_0fe817089ae44baf935e2b12288d2e01</doaj_id><sourcerecordid>A820571074</sourcerecordid><originalsourceid>FETCH-LOGICAL-d3968-e3ebc6199a308db49375cb4122722e2283b3b9bc8eea70b96021b755989e39c13</originalsourceid><addsrcrecordid>eNqNk9tu1DAQhiMEoqXwBggsISG42MWHHGxuUFVxWFSpEqfbaOJMEldOHGynom_Ho-Ftl6qLeoF8YWv8zT_j33aWPWV0zUTF3py7xU9g17ObcE0FK0pG72WHTAm-KjkV92-tD7JHIZxTWghZlg-zA6EqShktD7PfJ9ZMRoMlswcdjUbSOU9G03swE5LoEeKIUyQwtUQPsKXQm5DQQFxHRmyv0jvQxppoMFyR83AZjDYwhWsJM_U3om_JZgqmH2IgnXcjAeIxehdmTA1cINFucD6SEJf2kixhmwrkM8wwYUi7FswYSAsRGgj4OHvQgQ34ZDcfZd8_vP928ml1evZxc3J8umqFKuUKBTa6ZEqBoLJtciWqQjc547ziHDmXohGNarREhIo2qqScNVVRKKlQKM3EUfb8Wne2LtQ780MtWF7ljFVJ4CjbXBOtg_N69mYEf1k7MPVVwPm-Bp9ss1jTDiWrqFSAed5Ap0SBvEnNSNlypNtq73bVliY5rNMFeLB7ovs7kxnq3l3UjJWFTNecFF7tFLz7uWCI9WiCRmuTi27ZNS5pqXhCX_yD3n28HdVDOoGZOpcK661ofSw5LSpGqzxR6zuoNFocjU5PtTMpvpfwei8hMRF_xR6WEOrN1y__z5792Gdf3mIHBBuH4OwSjZvCPvjsttU3Hv_9I-IPlnQU6g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3147411728</pqid></control><display><type>article</type><title>Clinical practice for migraine treatment and characteristics of medical facilities and physicians treating migraine: Insights from a retrospective cohort study using a Japanese claims database</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Takizawa, Tsubasa ; Kitano, Takahiro ; Togo, Kanae ; Yoshikawa, Reiko ; Iijima, Masahiro</creator><creatorcontrib>Takizawa, Tsubasa ; Kitano, Takahiro ; Togo, Kanae ; Yoshikawa, Reiko ; Iijima, Masahiro</creatorcontrib><description>The real-world treatment patterns at medical facilities and their physicians' specialties treating migraine have not been fully investigated in Japan. Therefore, a retrospective cohort study aimed to describe real-world clinical practice and treatment patterns in Japanese patients with migraine according to medical facilities and physicians' specialties. Anonymized claims data of patients with migraine was obtained from JMDC Inc (January 2018-June 2023). Patient characteristics and treatment pattern according to medical facilities and physicians' specialties treating migraine were evaluated. Of 231,156 patients with migraine (mean age [SD], 38.8 [11.8] years; females, 65.3%), 81.8% had the first prescription at clinics (CPs), 42.5% underwent imaging tests, 44.4% visited general internal medicine, and 25.9% consulted neurosurgery at initial diagnosis. Imaging tests were carried out at CPs with specialists (59.4%), hospitals (HPs) with specialists (59.1%), HPs (32.9%), and CPs (26.9%) without specialists. Overall, 95.6% received acute treatment while 21.8% received preventive treatment. At facilities with specialists compared to without specialists, triptans were more frequently prescribed (67.9% vs 44.9%) whereas acetaminophen and nonsteroidal anti-inflammatory drugs were less frequently prescribed (52.4% vs 69.2%). Preventive treatment use was higher at facilities with specialists (27.4%) than without specialists (15.7%) and increased annually regardless of the type of medical institution. In Japan, only half of patients with migraine visited facilities with specialists at their first diagnosis, and specialists are more likely use migraine-specific and preventive drugs than nonspecialists. Therefore, there is a need for awareness among migraine patients that they should consult specialists and for enhancement of medical collaboration between specialists and nonspecialists.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0315610</identifier><identifier>PMID: 39700106</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acetaminophen ; Adult ; Analgesics ; Anti-inflammatory agents ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Antidepressants ; Beta blockers ; Care and treatment ; Clinical medicine ; Cohort analysis ; Databases, Factual ; Diagnosis ; Disease prevention ; Drug therapy ; Drugs ; East Asian People ; Evaluation ; Female ; Headache ; Headaches ; Health care facilities ; Health facilities ; Health insurance ; Health services ; Hospitals ; Humans ; Internal medicine ; Japan ; Male ; Medical imaging ; Medicine ; Medicine and Health Sciences ; Medicine, Preventive ; Middle Aged ; Migraine ; Migraine Disorders - drug therapy ; Migraine Disorders - therapy ; Monoclonal antibodies ; Nervous system ; Neurosurgery ; Nonsteroidal anti-inflammatory drugs ; Patients ; People and Places ; Physicians ; Physicians - statistics & numerical data ; Practice ; Practice guidelines (Medicine) ; Practice Patterns, Physicians' - statistics & numerical data ; Prescription drugs ; Preventive health services ; Research and Analysis Methods ; Retrospective Studies ; Surgery ; Tryptamines - therapeutic use ; Variables</subject><ispartof>PloS one, 2024-12, Vol.19 (12), p.e0315610</ispartof><rights>Copyright: © 2024 Takizawa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2024 Public Library of Science</rights><rights>2024 Takizawa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 Takizawa et al 2024 Takizawa et al</rights><rights>2024 Takizawa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-2605-7200 ; 0009-0002-2467-3149</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11658538/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11658538/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39700106$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takizawa, Tsubasa</creatorcontrib><creatorcontrib>Kitano, Takahiro</creatorcontrib><creatorcontrib>Togo, Kanae</creatorcontrib><creatorcontrib>Yoshikawa, Reiko</creatorcontrib><creatorcontrib>Iijima, Masahiro</creatorcontrib><title>Clinical practice for migraine treatment and characteristics of medical facilities and physicians treating migraine: Insights from a retrospective cohort study using a Japanese claims database</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The real-world treatment patterns at medical facilities and their physicians' specialties treating migraine have not been fully investigated in Japan. Therefore, a retrospective cohort study aimed to describe real-world clinical practice and treatment patterns in Japanese patients with migraine according to medical facilities and physicians' specialties. Anonymized claims data of patients with migraine was obtained from JMDC Inc (January 2018-June 2023). Patient characteristics and treatment pattern according to medical facilities and physicians' specialties treating migraine were evaluated. Of 231,156 patients with migraine (mean age [SD], 38.8 [11.8] years; females, 65.3%), 81.8% had the first prescription at clinics (CPs), 42.5% underwent imaging tests, 44.4% visited general internal medicine, and 25.9% consulted neurosurgery at initial diagnosis. Imaging tests were carried out at CPs with specialists (59.4%), hospitals (HPs) with specialists (59.1%), HPs (32.9%), and CPs (26.9%) without specialists. Overall, 95.6% received acute treatment while 21.8% received preventive treatment. At facilities with specialists compared to without specialists, triptans were more frequently prescribed (67.9% vs 44.9%) whereas acetaminophen and nonsteroidal anti-inflammatory drugs were less frequently prescribed (52.4% vs 69.2%). Preventive treatment use was higher at facilities with specialists (27.4%) than without specialists (15.7%) and increased annually regardless of the type of medical institution. In Japan, only half of patients with migraine visited facilities with specialists at their first diagnosis, and specialists are more likely use migraine-specific and preventive drugs than nonspecialists. Therefore, there is a need for awareness among migraine patients that they should consult specialists and for enhancement of medical collaboration between specialists and nonspecialists.</description><subject>Acetaminophen</subject><subject>Adult</subject><subject>Analgesics</subject><subject>Anti-inflammatory agents</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Antidepressants</subject><subject>Beta blockers</subject><subject>Care and treatment</subject><subject>Clinical medicine</subject><subject>Cohort analysis</subject><subject>Databases, Factual</subject><subject>Diagnosis</subject><subject>Disease prevention</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>East Asian People</subject><subject>Evaluation</subject><subject>Female</subject><subject>Headache</subject><subject>Headaches</subject><subject>Health care facilities</subject><subject>Health facilities</subject><subject>Health insurance</subject><subject>Health services</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Internal medicine</subject><subject>Japan</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Medicine, Preventive</subject><subject>Middle Aged</subject><subject>Migraine</subject><subject>Migraine Disorders - drug therapy</subject><subject>Migraine Disorders - therapy</subject><subject>Monoclonal antibodies</subject><subject>Nervous system</subject><subject>Neurosurgery</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Patients</subject><subject>People and Places</subject><subject>Physicians</subject><subject>Physicians - statistics & numerical data</subject><subject>Practice</subject><subject>Practice guidelines (Medicine)</subject><subject>Practice Patterns, Physicians' - statistics & numerical data</subject><subject>Prescription drugs</subject><subject>Preventive health services</subject><subject>Research and Analysis Methods</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Tryptamines - therapeutic use</subject><subject>Variables</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk9tu1DAQhiMEoqXwBggsISG42MWHHGxuUFVxWFSpEqfbaOJMEldOHGynom_Ho-Ftl6qLeoF8YWv8zT_j33aWPWV0zUTF3py7xU9g17ObcE0FK0pG72WHTAm-KjkV92-tD7JHIZxTWghZlg-zA6EqShktD7PfJ9ZMRoMlswcdjUbSOU9G03swE5LoEeKIUyQwtUQPsKXQm5DQQFxHRmyv0jvQxppoMFyR83AZjDYwhWsJM_U3om_JZgqmH2IgnXcjAeIxehdmTA1cINFucD6SEJf2kixhmwrkM8wwYUi7FswYSAsRGgj4OHvQgQ34ZDcfZd8_vP928ml1evZxc3J8umqFKuUKBTa6ZEqBoLJtciWqQjc547ziHDmXohGNarREhIo2qqScNVVRKKlQKM3EUfb8Wne2LtQ780MtWF7ljFVJ4CjbXBOtg_N69mYEf1k7MPVVwPm-Bp9ss1jTDiWrqFSAed5Ap0SBvEnNSNlypNtq73bVliY5rNMFeLB7ovs7kxnq3l3UjJWFTNecFF7tFLz7uWCI9WiCRmuTi27ZNS5pqXhCX_yD3n28HdVDOoGZOpcK661ofSw5LSpGqzxR6zuoNFocjU5PtTMpvpfwei8hMRF_xR6WEOrN1y__z5792Gdf3mIHBBuH4OwSjZvCPvjsttU3Hv_9I-IPlnQU6g</recordid><startdate>20241219</startdate><enddate>20241219</enddate><creator>Takizawa, Tsubasa</creator><creator>Kitano, Takahiro</creator><creator>Togo, Kanae</creator><creator>Yoshikawa, Reiko</creator><creator>Iijima, Masahiro</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2605-7200</orcidid><orcidid>https://orcid.org/0009-0002-2467-3149</orcidid></search><sort><creationdate>20241219</creationdate><title>Clinical practice for migraine treatment and characteristics of medical facilities and physicians treating migraine: Insights from a retrospective cohort study using a Japanese claims database</title><author>Takizawa, Tsubasa ; Kitano, Takahiro ; Togo, Kanae ; Yoshikawa, Reiko ; Iijima, Masahiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d3968-e3ebc6199a308db49375cb4122722e2283b3b9bc8eea70b96021b755989e39c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acetaminophen</topic><topic>Adult</topic><topic>Analgesics</topic><topic>Anti-inflammatory agents</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Antidepressants</topic><topic>Beta blockers</topic><topic>Care and treatment</topic><topic>Clinical medicine</topic><topic>Cohort analysis</topic><topic>Databases, Factual</topic><topic>Diagnosis</topic><topic>Disease prevention</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>East Asian People</topic><topic>Evaluation</topic><topic>Female</topic><topic>Headache</topic><topic>Headaches</topic><topic>Health care facilities</topic><topic>Health facilities</topic><topic>Health insurance</topic><topic>Health services</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Internal medicine</topic><topic>Japan</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Medicine, Preventive</topic><topic>Middle Aged</topic><topic>Migraine</topic><topic>Migraine Disorders - drug therapy</topic><topic>Migraine Disorders - therapy</topic><topic>Monoclonal antibodies</topic><topic>Nervous system</topic><topic>Neurosurgery</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Patients</topic><topic>People and Places</topic><topic>Physicians</topic><topic>Physicians - statistics & numerical data</topic><topic>Practice</topic><topic>Practice guidelines (Medicine)</topic><topic>Practice Patterns, Physicians' - statistics & numerical data</topic><topic>Prescription drugs</topic><topic>Preventive health services</topic><topic>Research and Analysis Methods</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Tryptamines - therapeutic use</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takizawa, Tsubasa</creatorcontrib><creatorcontrib>Kitano, Takahiro</creatorcontrib><creatorcontrib>Togo, Kanae</creatorcontrib><creatorcontrib>Yoshikawa, Reiko</creatorcontrib><creatorcontrib>Iijima, Masahiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takizawa, Tsubasa</au><au>Kitano, Takahiro</au><au>Togo, Kanae</au><au>Yoshikawa, Reiko</au><au>Iijima, Masahiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical practice for migraine treatment and characteristics of medical facilities and physicians treating migraine: Insights from a retrospective cohort study using a Japanese claims database</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2024-12-19</date><risdate>2024</risdate><volume>19</volume><issue>12</issue><spage>e0315610</spage><pages>e0315610-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The real-world treatment patterns at medical facilities and their physicians' specialties treating migraine have not been fully investigated in Japan. Therefore, a retrospective cohort study aimed to describe real-world clinical practice and treatment patterns in Japanese patients with migraine according to medical facilities and physicians' specialties. Anonymized claims data of patients with migraine was obtained from JMDC Inc (January 2018-June 2023). Patient characteristics and treatment pattern according to medical facilities and physicians' specialties treating migraine were evaluated. Of 231,156 patients with migraine (mean age [SD], 38.8 [11.8] years; females, 65.3%), 81.8% had the first prescription at clinics (CPs), 42.5% underwent imaging tests, 44.4% visited general internal medicine, and 25.9% consulted neurosurgery at initial diagnosis. Imaging tests were carried out at CPs with specialists (59.4%), hospitals (HPs) with specialists (59.1%), HPs (32.9%), and CPs (26.9%) without specialists. Overall, 95.6% received acute treatment while 21.8% received preventive treatment. At facilities with specialists compared to without specialists, triptans were more frequently prescribed (67.9% vs 44.9%) whereas acetaminophen and nonsteroidal anti-inflammatory drugs were less frequently prescribed (52.4% vs 69.2%). Preventive treatment use was higher at facilities with specialists (27.4%) than without specialists (15.7%) and increased annually regardless of the type of medical institution. In Japan, only half of patients with migraine visited facilities with specialists at their first diagnosis, and specialists are more likely use migraine-specific and preventive drugs than nonspecialists. Therefore, there is a need for awareness among migraine patients that they should consult specialists and for enhancement of medical collaboration between specialists and nonspecialists.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>39700106</pmid><doi>10.1371/journal.pone.0315610</doi><tpages>e0315610</tpages><orcidid>https://orcid.org/0000-0003-2605-7200</orcidid><orcidid>https://orcid.org/0009-0002-2467-3149</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2024-12, Vol.19 (12), p.e0315610 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_3147411728 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry |
| subjects | Acetaminophen Adult Analgesics Anti-inflammatory agents Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antidepressants Beta blockers Care and treatment Clinical medicine Cohort analysis Databases, Factual Diagnosis Disease prevention Drug therapy Drugs East Asian People Evaluation Female Headache Headaches Health care facilities Health facilities Health insurance Health services Hospitals Humans Internal medicine Japan Male Medical imaging Medicine Medicine and Health Sciences Medicine, Preventive Middle Aged Migraine Migraine Disorders - drug therapy Migraine Disorders - therapy Monoclonal antibodies Nervous system Neurosurgery Nonsteroidal anti-inflammatory drugs Patients People and Places Physicians Physicians - statistics & numerical data Practice Practice guidelines (Medicine) Practice Patterns, Physicians' - statistics & numerical data Prescription drugs Preventive health services Research and Analysis Methods Retrospective Studies Surgery Tryptamines - therapeutic use Variables |
| title | Clinical practice for migraine treatment and characteristics of medical facilities and physicians treating migraine: Insights from a retrospective cohort study using a Japanese claims database |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A35%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20practice%20for%20migraine%20treatment%20and%20characteristics%20of%20medical%20facilities%20and%20physicians%20treating%20migraine:%20Insights%20from%20a%20retrospective%20cohort%20study%20using%20a%20Japanese%20claims%20database&rft.jtitle=PloS%20one&rft.au=Takizawa,%20Tsubasa&rft.date=2024-12-19&rft.volume=19&rft.issue=12&rft.spage=e0315610&rft.pages=e0315610-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0315610&rft_dat=%3Cgale_plos_%3EA820571074%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3147411728&rft_id=info:pmid/39700106&rft_galeid=A820571074&rft_doaj_id=oai_doaj_org_article_0fe817089ae44baf935e2b12288d2e01&rfr_iscdi=true |